Trinity Biotech Plc Stock Performance
| TRIB Stock | USD 0.91 0.12 15.19% |
Trinity Biotech has a performance score of 1 on a scale of 0 to 100. The entity has a beta of 0.37, which indicates possible diversification benefits within a given portfolio. As returns on the market increase, Trinity Biotech's returns are expected to increase less than the market. However, during the bear market, the loss of holding Trinity Biotech is expected to be smaller as well. Trinity Biotech plc right now has a risk of 8.13%. Please validate Trinity Biotech sortino ratio, skewness, price action indicator, as well as the relationship between the potential upside and rate of daily change , to decide if Trinity Biotech will be following its existing price patterns.
Risk-Adjusted Performance
Weak
Weak | Strong |
Compared to the overall equity markets, risk-adjusted returns on investments in Trinity Biotech plc are ranked lower than 1 (%) of all global equities and portfolios over the last 90 days. Despite somewhat unfluctuating forward indicators, Trinity Biotech may actually be approaching a critical reversion point that can send shares even higher in February 2026. ...more
Last Split Factor 1:5 | Dividend Date 2015-07-01 | Ex Dividend Date 2015-06-05 | Last Split Date 2024-02-23 |
1 | USWNTs Emma Hayes weighs in on Trinity Rodmans future, NWSL salary cap | 11/19/2025 |
2 | Icon Advisers Inc. Co. Reduces Holdings in Trinity Industries, Inc. TRN | 12/01/2025 |
3 | Spirit cautiously optimistic about Trinity Rodman negotiations and working with NWSL | 12/10/2025 |
4 | Trinity Biotech Stock Jumps 60 percent After Major Breakthrough | 12/23/2025 |
5 | What Caused Multi Ways Holdings To Soar Nearly 49 percent In After-Hours Trading | 12/24/2025 |
6 | Callous day care owner allegedly killed infant by bashing his head into floor during diaper change | 12/31/2025 |
7 | Trinity Industries, Inc. Completes Railcar Partnership Restructuring Raises EPS Guidance | 01/06/2026 |
8 | The best film TV to watch in 2026 | 01/07/2026 |
9 | USWNT January roster Three thoughts as Trinity Rodman returns in 2026 | 01/08/2026 |
10 | Trinity Industries Is Up 5.1 percent After Raising 2025 EPS Guidance To 3.053.20 - Whats Changed | 01/12/2026 |
11 | Unpacking Q3 Earnings Trinity In The Context Of Other Heavy Transportation Equipment Stocks | 01/16/2026 |
12 | Starlight Investments clbre lachvement de Trinity Heights, la nouvelle tour rsidentielle de 60 tages de Manchester. | 01/20/2026 |
13 | Trinity Rodman becomes highest-paid womens soccer player in the world with Washington Spirit deal | 01/23/2026 |
| Begin Period Cash Flow | 3.7 M | |
| Total Cashflows From Investing Activities | -23 M |
Trinity Biotech Relative Risk vs. Return Landscape
If you would invest 102.00 in Trinity Biotech plc on October 27, 2025 and sell it today you would lose (11.00) from holding Trinity Biotech plc or give up 10.78% of portfolio value over 90 days. Trinity Biotech plc is currently generating 0.1122% in daily expected returns and assumes 8.1301% risk (volatility on return distribution) over the 90 days horizon. In different words, 73% of stocks are less volatile than Trinity, and 98% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
Trinity Biotech Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Trinity Biotech's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Trinity Biotech plc, and traders can use it to determine the average amount a Trinity Biotech's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Based on monthly moving average Trinity Biotech is performing at about 1% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Trinity Biotech by adding it to a well-diversified portfolio.
Trinity Biotech Fundamentals Growth
Trinity Stock prices reflect investors' perceptions of the future prospects and financial health of Trinity Biotech, and Trinity Biotech fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Trinity Stock performance.
| Return On Equity | -19.13 | ||||
| Return On Asset | -0.11 | ||||
| Profit Margin | (0.52) % | ||||
| Operating Margin | (0.43) % | ||||
| Current Valuation | 127.95 M | ||||
| Shares Outstanding | 18.63 M | ||||
| Price To Earning | 31.00 X | ||||
| Price To Book | 5.11 X | ||||
| Price To Sales | 0.35 X | ||||
| Revenue | 61.55 M | ||||
| Gross Profit | 21.44 M | ||||
| EBITDA | (16.91 M) | ||||
| Net Income | (31.79 M) | ||||
| Cash And Equivalents | 10.01 M | ||||
| Cash Per Share | 0.41 X | ||||
| Total Debt | 100.76 M | ||||
| Current Ratio | 3.66 X | ||||
| Book Value Per Share | (1.96) X | ||||
| Cash Flow From Operations | (4.19 M) | ||||
| Earnings Per Share | (1.80) X | ||||
| Market Capitalization | 15.89 M | ||||
| Total Asset | 103.29 M | ||||
| Retained Earnings | (79.12 M) | ||||
| Working Capital | 9.03 M | ||||
| Current Asset | 151 M | ||||
| Current Liabilities | 21 M | ||||
About Trinity Biotech Performance
By analyzing Trinity Biotech's fundamental ratios, stakeholders can gain valuable insights into Trinity Biotech's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Trinity Biotech has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Trinity Biotech has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
| Last Reported | Projected for Next Year | ||
| Days Of Inventory On Hand | 158.66 | 163.83 | |
| Return On Tangible Assets | (0.70) | (0.67) | |
| Return On Capital Employed | (0.27) | (0.25) | |
| Return On Assets | (0.28) | (0.26) | |
| Return On Equity | 0.81 | 0.85 |
Things to note about Trinity Biotech plc performance evaluation
Checking the ongoing alerts about Trinity Biotech for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Trinity Biotech plc help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Trinity Biotech plc had very high historical volatility over the last 90 days | |
| Trinity Biotech plc has some characteristics of a very speculative penny stock | |
| Trinity Biotech plc has high likelihood to experience some financial distress in the next 2 years | |
| The company reported the previous year's revenue of 61.55 M. Net Loss for the year was (31.79 M) with profit before overhead, payroll, taxes, and interest of 21.44 M. | |
| Trinity Biotech plc currently holds about 10.01 M in cash with (4.19 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.41. | |
| Trinity Biotech plc has a poor financial position based on the latest SEC disclosures | |
| Roughly 66.0% of the company shares are owned by institutional investors | |
| Latest headline from thelincolnianonline.com: Cingulate Inc. Receives Average Rating of Moderate Buy from Brokerages |
- Analyzing Trinity Biotech's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Trinity Biotech's stock is overvalued or undervalued compared to its peers.
- Examining Trinity Biotech's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Trinity Biotech's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Trinity Biotech's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Trinity Biotech's stock. These opinions can provide insight into Trinity Biotech's potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for Trinity Stock analysis
When running Trinity Biotech's price analysis, check to measure Trinity Biotech's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Trinity Biotech is operating at the current time. Most of Trinity Biotech's value examination focuses on studying past and present price action to predict the probability of Trinity Biotech's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Trinity Biotech's price. Additionally, you may evaluate how the addition of Trinity Biotech to your portfolios can decrease your overall portfolio volatility.
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| Transaction History View history of all your transactions and understand their impact on performance | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation |